Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid Dose and ACT Level in Cardiac Surgery
NCT06109155Phase 4Recruiting
- Sponsor
- Taichung Veterans General Hospital
- Start
- Feb 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tranexamic acid in hemorrhage (4 arms), sponsored by Taichung Veterans General Hospital. Primary endpoints: Postoperative bleeding volume at 24 hours and Blood transfusion volume. Started Feb 2024; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT06109155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06109155.